Quantinuum (NASDAQ:QNT) Stock Rating Upgraded by UBS Group

Quantinuum (NASDAQ:QNTGet Free Report) was upgraded by investment analysts at UBS Group to a “strong-buy” rating in a report released on Monday,Zacks.com reports.

Other equities research analysts have also issued research reports about the company. TD Cowen assumed coverage on Quantinuum in a research note on Monday. They set a “buy” rating on the stock. JPMorgan Chase & Co. assumed coverage on Quantinuum in a report on Monday. They set an “overweight” rating and a $97.00 price objective for the company. Bank of America assumed coverage on Quantinuum in a research report on Monday. They set a “buy” rating and a $100.00 target price on the stock. Craig Hallum initiated coverage on Quantinuum in a research note on Monday. They set a “buy” rating and a $100.00 price target for the company. Finally, Morgan Stanley began coverage on shares of Quantinuum in a research report on Monday. They issued an “equal weight” rating and a $78.00 price objective on the stock. Four equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Quantinuum currently has a consensus rating of “Buy” and a consensus price target of $98.75.

View Our Latest Analysis on Quantinuum

Quantinuum Price Performance

QNT stock opened at $81.74 on Monday. Quantinuum has a 52 week low of $50.10 and a 52 week high of $82.30.

Insider Buying and Selling at Quantinuum

In other news, Director Michal Stepniak bought 13,333 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was acquired at an average price of $60.00 per share, for a total transaction of $799,980.00. Following the acquisition, the director owned 13,333 shares of the company’s stock, valued at $799,980. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Kenneth D. Denman purchased 14,000 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average price of $60.00 per share, for a total transaction of $840,000.00. Following the acquisition, the director directly owned 19,833 shares of the company’s stock, valued at $1,189,980. This trade represents a 240.01% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have bought 411,032 shares of company stock worth $24,661,920.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Several major firms initiated or upgraded coverage on Quantinuum with upbeat ratings, including “strong-buy” calls from Cantor Fitzgerald, Evercore, and Jefferies, plus buy/overweight ratings from JPMorgan, Bank of America, Needham, Mizuho, Craig Hallum, Rosenblatt, and others. Many of these targets imply meaningful upside from recent levels.
  • Positive Sentiment: Analysts highlighted Quantinuum as a key quantum-computing name, with one report calling it a new Wall Street favorite and another noting triple-digit upside potential, reinforcing the stock’s momentum. Article Title
  • Positive Sentiment: Recent insider-buying headlines also supported sentiment, including reports of about $25 million in post-IPO insider purchases and a congressman’s disclosed purchase of Quantinuum stock, which investors may interpret as a confidence signal. Article Title
  • Positive Sentiment: Coverage linking the stock to a recent quantum-computing executive order and noting a sharp share-price move added to the momentum trade around the name. Article Title

About Quantinuum

(Get Free Report)

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.

Recommended Stories

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.